Polycystic ovary syndrome (PCOS) is the most common hormonal disorder in women of reproductive age, and it affects fertility at multiple levels. Infertility affects roughly 47% of women with PCOS, compared to about 16% of women without it. That translates to a 15-fold increased risk of infertility. But the picture is more nuanced than “PCOS means you can’t get pregnant.” The condition disrupts ovulation, egg quality, and even the uterine lining’s ability to support a pregnancy, yet most women with PCOS can conceive with the right interventions.
Why Ovulation Stalls
The most direct way PCOS interferes with fertility is by preventing ovulation. In a typical cycle, a group of small follicles begins developing in the ovaries, and one “dominant” follicle matures fully, releases an egg, and triggers the second half of the menstrual cycle. In PCOS, that process stalls partway through. Follicles start growing but hit a wall at about 5 to 8 millimeters and stop maturing. The result is a collection of small, stalled follicles visible on ultrasound, but no egg release.
This happens because of a hormone imbalance at the brain level. Normally, two hormones from the pituitary gland, LH and FSH, work in a balanced ratio (roughly 1:1 or 2:1) to guide follicle development. In PCOS, LH pulses become faster and stronger, pushing the ratio to 2:1 or even 3:1. The excess LH drives the ovaries to produce more androgens (sometimes called “male hormones,” though all women produce them), while FSH stays too low to push any single follicle to full maturity. Without a dominant follicle, there’s no ovulation, and without ovulation, there’s no chance of natural conception that cycle.
The Role of Insulin Resistance
About 50 to 70% of women with PCOS have some degree of insulin resistance, and this adds a second engine driving the problem. When insulin levels stay chronically high, insulin directly stimulates the ovary’s outer layer (the theca cells) to ramp up androgen production. This happens through a different biological pathway than the one insulin uses to manage blood sugar, which is why you can be insulin resistant for glucose purposes while your ovaries remain highly sensitive to insulin’s hormonal effects.
High insulin also amplifies the effect of LH on those same cells, creating a feedback loop: more insulin leads to more androgens, which disrupts follicle development, which prevents ovulation. This is why weight and metabolic health play such a large role in PCOS fertility. It also explains why improving insulin sensitivity, whether through weight loss or medication, can sometimes restart ovulation on its own.
Egg Quality and Early Pregnancy Loss
Even when women with PCOS do ovulate, either spontaneously or with medical help, the eggs may not be in optimal condition. During IVF cycles, women with PCOS often produce more eggs than average, but those eggs tend to have lower fertilization rates and higher rates of failed embryo transfers. The hormonal environment the eggs develop in, bathed in excess androgens and insulin with insufficient FSH, appears to compromise the maturation process itself.
This contributes to a significantly higher rate of early pregnancy loss. Women with PCOS face roughly three to five times the risk of miscarriage compared to women without the condition. After IVF specifically, miscarriage rates of about 36% have been reported in women with PCOS versus roughly 24% in women without it. The causes are likely a combination of egg quality issues, embryo quality, and problems with the uterine environment. Higher body weight and insulin resistance appear to compound the risk further.
The Uterine Lining Works Against Implantation
Even if a healthy embryo forms, PCOS can make the uterine lining less welcoming. For a pregnancy to establish, the endometrium needs to enter a brief “receptive window” where it’s primed to accept an embryo. In PCOS, several things go wrong during this window.
Elevated androgens weaken the tight junctions between cells in the endometrial lining, creating a less stable surface for implantation. The lining also overexpresses certain proteins that keep it in a non-receptive state, essentially putting up a molecular “closed” sign during the window when it should be open. Insulin resistance adds another layer of damage by impairing the energy-producing structures (mitochondria) within uterine cells. Progesterone resistance, where the lining doesn’t respond properly to progesterone’s signals to prepare for pregnancy, further reduces the chances of successful implantation.
These endometrial changes mean that even women with PCOS who ovulate regularly can still face reduced fertility without obvious cycle irregularities. It’s worth noting that ovulatory dysfunction can occur even with seemingly regular periods, which is one reason PCOS-related subfertility sometimes goes unexplained longer than it should.
How PCOS Fertility Treatment Works
The goal of first-line treatment is simple: get one mature follicle to develop and release an egg. Two oral medications are commonly used for ovulation induction, and they aren’t equally effective.
Letrozole, which works by temporarily lowering estrogen to trick the brain into releasing more FSH, produces significantly better results than the older standard, clomiphene citrate. In head-to-head comparisons, letrozole achieved a live birth rate of 25.4% per treatment cycle compared to 10.9% with clomiphene. Pregnancy rates were also nearly double (29% versus 15.4%). Interestingly, ovulation rates were similar between the two drugs (about 68% versus 64%), meaning the advantage of letrozole comes from what happens after ovulation: better egg quality, better hormonal support for the uterine lining, or both. Letrozole also produces single-follicle development more reliably (77% of cycles versus 53%), which lowers the risk of twins.
For women who don’t respond to oral medications, injectable hormones that directly supply FSH are the next step, followed by IVF for those who need it. PCOS is actually one of the more treatable causes of infertility because the underlying equipment (the ovaries, uterus, and eggs) is present. The challenge is hormonal regulation, not structural damage.
Weight Loss and Ovulation Recovery
For women with PCOS who carry extra weight, losing as little as 5% of total body weight can restore ovulation. In a 200-pound woman, that’s just 10 pounds. This modest loss reduces central body fat, improves insulin sensitivity, and lowers circulating androgen levels enough to allow follicle development to resume.
This doesn’t mean weight loss is easy, and it’s not the answer for every woman with PCOS (lean PCOS exists and affects fertility through the same hormonal pathways without a weight component). But for those with elevated BMI and insulin resistance, lifestyle changes represent one of the few interventions that address the root hormonal dysfunction rather than working around it. Improved insulin sensitivity reduces the androgen overproduction that stalls follicle growth, lowers the risk of miscarriage, and creates a more receptive uterine lining.
Fertility Beyond Ovulation
One of the most important things to understand about PCOS and fertility is that the condition affects the entire reproductive chain, not just whether you ovulate. The hormonal environment alters egg maturation inside the follicle, changes the signals the uterine lining receives, and shifts the metabolic conditions an early embryo develops in. This is why treatment approaches that address the underlying hormonal imbalances (improving insulin sensitivity, reducing androgens, supporting progesterone) tend to produce better outcomes than simply forcing ovulation with medication alone.
PCOS accounts for roughly 40% of all women who undergo infertility treatment. But the condition’s high prevalence in fertility clinics reflects how common it is, not how hopeless it is. The majority of women with PCOS who pursue treatment do eventually conceive. The path may involve medication, lifestyle changes, or assisted reproduction, but the biological barriers PCOS creates are among the most well-understood and treatable in reproductive medicine.